Back
abrdn Life Sciences Investors Vs. VanEck Biotech ETF Industry Stock Comparison
Sell
29
HQL
abrdn Life Sciences Investors
Last Price:
14.92
Seasonality Move:
6.15%
Sell
36
BBH
VanEck Biotech ETF
Last Price:
171.98
Seasonality Move:
5.76%
Sell
29
abrdn Life Sciences Investors (HQL)
is a Sell
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
- The current abrdn Life Sciences Investors [HQL] share price is $14.71. The Score for HQL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- HQL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
VanEck Biotech ETF (BBH)
is a Sell
Is VanEck Biotech ETF a Buy, Sell or Hold?
- The current VanEck Biotech ETF [BBH] share price is $170.41. The Score for BBH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- BBH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $14.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing slight buying pressure.
BBH Stock Price Chart
What is VanEck Biotech ETF's stock price today?
-
The VanEck Biotech ETF share price today is $170.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBH is experiencing selling pressure, which indicates risk of future bearish movement.
HQL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 40.94 | Sell |
| Chaikin Money Flow: | 3038 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.78 - 15.08) | Sell |
| Bollinger Bands (100): | (14.47 - 15.43) | Sell |
BBH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.75 | Sell |
| Relative Strength Index (14 RSI): | 35.91 | Sell |
| Chaikin Money Flow: | -1257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (171.84 - 177.12) | Sell |
| Bollinger Bands (100): | (171.26 - 180.14) | Sell |
HQL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.81 | Sell |
| 20-day SMA: | 14.93 | Sell |
| 50-day SMA: | 15.04 | Sell |
| 200-day SMA: | 14.28 | Buy |
| 8-day EMA: | 14.79 | Sell |
| 20-day EMA: | 14.9 | Sell |
| 50-day EMA: | 14.97 | Sell |
| 200-day EMA: | 14.42 | Buy |
BBH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 171.23 | Sell |
| 20-day SMA: | 174.29 | Sell |
| 50-day SMA: | 176.71 | Sell |
| 200-day SMA: | 169.68 | Buy |
| 8-day EMA: | 171.62 | Sell |
| 20-day EMA: | 173.52 | Sell |
| 50-day EMA: | 175.21 | Sell |
| 200-day EMA: | 170.75 | Sell |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
VanEck Biotech ETF Earnings Growth & BBH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
abrdn Life Sciences Investors Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
VanEck Biotech ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||